Next Article in Journal / Special Issue
Herb-Drug Pharmacokinetic Interactions: Transport and Metabolism of Indinavir in the Presence of Selected Herbal Products
Previous Article in Journal
7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment
Previous Article in Special Issue
Bioactive Constituents from the Aerial Parts of Lippia triphylla
Open AccessArticle

Safety Evaluation, in Vitro and in Vivo Antioxidant Activity of the Flavonoid-Rich Extract from Maydis stigma

College of Chemical and Pharmaceutical Engineering, Jilin Institute of Chemical Technology, Jilin 132022, China
College of pharmacy, Zhengzhou University, Zhengzhou 450001, China
Department of Mathematics, School of Public Health, Jilin Medical College, Jilin 132013, China
Author to whom correspondence should be addressed.
Academic Editor: Christopher W. K. Lam
Molecules 2015, 20(12), 22102-22112;
Received: 29 October 2015 / Revised: 4 December 2015 / Accepted: 7 December 2015 / Published: 10 December 2015
(This article belongs to the Collection Herbal Medicine Research)
This study aimed to assess the acute toxicity and safety of flavonoid-rich extract from Maydis stigma (FMS) in mice. The in vitro antioxidant activity of FMS was determined by 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,2′-azinobis-(3-ethyl-benzthiazoline-6-sulphonate) (ABTS) scavenging assays. Furthermore, the in vivo antioxidant of FMS against ethanol-induced oxidative damage in mice was determined by analysis of the serum total superoxide dismutase (T-SOD) activity, malondialdehyde (MDA) content, liver tissue glutathione (GSH) content, and protein carbonyl (PC) content in liver tissue. The oral administration of FMS at doses of 30 g/kg did not cause death in mice, and there were no significant biologically adverse effects in mice. These results indicated that the median lethal dose (LD50) is higher than this dose. The IC50 values of FMS for the DPPH and ABTS scavenging activity were 50.73 and 0.23 mg/mL, respectively. Meanwhile, FMS could significantly enhance T-SOD activity, reduce MDA content in the serum, increase GSH content, and decrease PC content in the liver tissue at the tested doses (25, 50, 100, 200 mg/kg·day). These results indicate that FMS can be generally regarded as safe and used potentially as a bioactive source of natural antioxidants. View Full-Text
Keywords: flavonoids; Maydis stigma; acute toxicity; antioxidant activity flavonoids; Maydis stigma; acute toxicity; antioxidant activity
Show Figures

Figure 1

MDPI and ACS Style

Peng, K.-Z.; Yang, X.; Zhou, H.-L.; Pan, S.-X. Safety Evaluation, in Vitro and in Vivo Antioxidant Activity of the Flavonoid-Rich Extract from Maydis stigma. Molecules 2015, 20, 22102-22112.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop